BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34177897)

  • 1. Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.
    Laudanski K; Jihane H; Antalosky B; Ghani D; Phan U; Hernandez R; Okeke T; Wu J; Rader D; Susztak K
    Front Immunol; 2021; 12():650465. PubMed ID: 34177897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure.
    Laudanski K; Okeke T; Hajj J; Siddiq K; Rader DJ; Wu J; Susztak K
    Sci Rep; 2021 Oct; 11(1):19675. PubMed ID: 34608231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects.
    Hashimoto I; Wada J; Hida A; Baba M; Miyatake N; Eguchi J; Shikata K; Makino H
    Obesity (Silver Spring); 2006 May; 14(5):799-811. PubMed ID: 16855189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
    Acevedo N; Escamilla-Gil JM; Espinoza H; Regino R; Ramírez J; Florez de Arco L; Dennis R; Torres-Duque CA; Caraballo L
    Front Immunol; 2021; 12():678661. PubMed ID: 34335580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cytokines eotaxin, MIP-1α, MCP-4, and vascular endothelial growth factor in acute lower respiratory tract infection.
    Relster MM; Holm A; Pedersen C
    APMIS; 2017 Feb; 125(2):148-156. PubMed ID: 27859623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
    Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
    Front Immunol; 2021; 12():763292. PubMed ID: 34938289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes.
    Uranga-Murillo I; Morte E; Hidalgo S; Pesini C; García-Mulero S; Sierra JL; Santiago L; Arias M; De Miguel D; Encabo-Berzosa MDM; Gracia-Tello B; Sanz-Pamplona R; Martinez-Lostao L; Galvez EM; Paño-Pardo JR; Ramirez-Labrada A; Pardo J
    Theranostics; 2022; 12(1):290-306. PubMed ID: 34987646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum chemokine profile in patients with bullous pemphigoid.
    Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
    Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males.
    Fonseca W; Asai N; Yagi K; Malinczak CA; Savickas G; Johnson CC; Murray S; Zoratti EM; Lukacs NW; Li J; Schuler Iv CF
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
    Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
    Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency, weak MCP-1 secretion and exhausted immune status of peripheral monocytes were associated with progression of severe enterovirus A71-infected hand, foot and mouth disease.
    Pei X; Fan X; Zhang H; Duan H; Xu C; Xie B; Wang L; Li X; Peng Y; Shen T
    Clin Exp Immunol; 2019 Jun; 196(3):353-363. PubMed ID: 30697697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron Related Biomarkers Predict Disease Severity in a Cohort of Portuguese Adult Patients during COVID-19 Acute Infection.
    Moreira AC; Teles MJ; Silva T; Bento CM; Alves IS; Pereira L; Guimarães JT; Porto G; Oliveira P; Gomes MS
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19.
    Jøntvedt Jørgensen M; Holter JC; Christensen EE; Schjalm C; Tonby K; Pischke SE; Jenum S; Skeie LG; Nur S; Lind A; Opsand H; Enersen TB; Grøndahl R; Hermann A; Dudman S; Muller F; Ueland T; Mollnes TE; Aukrust P; Heggelund L; Holten AR; Dyrhol-Riise AM
    Sci Rep; 2020 Dec; 10(1):21697. PubMed ID: 33303843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study.
    Hau SO; Svensson M; Petersson A; Eberhard J; Jirström K
    BMC Cancer; 2023 Nov; 23(1):1074. PubMed ID: 37936126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.